Understanding the Pathogenesis and Treatment of Childhood Onset Dermatomyositis - Related Studies

Understanding the Pathogenesis and Treatment of Childhood Onset Dermatomyositis

This study has been terminated.

Study NCT00035958. Last updated on January 2, 2007. Information provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Dermatomyositis

2	More general conditions related to this trial
		Connective Tissue Diseases
		Muscular Diseases
		Musculoskeletal Diseases
		Myositis
		Nervous System Diseases
		Neuromuscular Diseases
		Polymyositis
		Skin Diseases

3	Interventions listed in this trial
		Prednisone
		Methotrexate
		Etanercept

4	Additional drug interventions recognized in this trial
		TNFR-Fc fusion protein

5	More general drug interventions related to this trial
		Abortifacient Agents
		Abortifacient Agents, Nonsteroidal
		Analgesics
		Analgesics, Non-Narcotic
		Anti-Inflammatory Agents
		Anti-Inflammatory Agents, Non-Steroidal
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Antineoplastic Agents, Hormonal
		Antirheumatic Agents
		Central Nervous System Agents
		Dermatologic Agents
		Enzyme Inhibitors
		Folic Acid Antagonists
		Gastrointestinal Agents
		Glucocorticoids
		Hormones
		Hormones, Hormone Substitutes, and Hormone Antagonists
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Nucleic Acid Synthesis Inhibitors
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Reproductive Control Agents
		Sensory System Agents
		Therapeutic Uses

6	Sponsors listed in this trial
		National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
		Immunex Corporation